Study Technical success, (%) Clinical success, (%) Adverse events DEN Walter et al. [20 ], 2015, Netherlands 98% (60/61) (total) WON 81% (35/43) PP 93% (13/14) 4 infection/occlusion 1 perforation WON 15/35 Gornals et al. [22 ], 2015, Spain WON 100% (13/13) WON 100% (13/13) 2 bleeding 1 infection-stent migration 1 infection-stent occlusion WON 13 Shah et al. [3 ], 2015, international 91% (30/33) (total) 81.8% (27/33) (total) 3 abdominal pain 1 stent migration and infection 1 stent dislodgement 11 Rinninella et al. [24 ], 2015, Italy WON 98.7% (74/75) PP 100% (18/18) WON 90.7% (68/75) PP 100% (18/18) 1 massive bleeding 1 perforation 1 pneumoperitoneum 1 postdrainage infection 1 stent displacement/migration 33 Sharaiha et al. [23 ], 2016, USA WON 100% (124/124) WON 86.3% (107/124) 7 stents migration 7 stent occlusion 7 infection 2 bleeding 78 Yoo et al. [25 ], 2017, USA WON 100% (22/22) PP 100% (3/3) WON 95.5% (21/22) PP 100% (3/3) 0 WON 1 Bekkali et al. [19 ], 2017, UK WON 97% (32/33) WON 78.1% (25/32) 1 stent misplacement 4 additional percutaneous drain 3 dislodged stent NA Aburajab et al. [27 ],, 2018, USA PP 96% (23/24) PP 91% (21/23) 1 perforation 4 infection 1 migration NA Adler DG et al. [28 ], 2018, USA 99% (79/80) 90% (72/80) 4 perforation 2 suprainfection 13 bleeding 63 Anderloni et al. [29 ], 2018, Italy 100% (19/19) 83.3% (15/19) 1 occlusion and infection 1 migration NA Yang et al. [30 ], 2018, USA PP 98.3% (57/58) WON 98.4% (63/64) PP 95.5% (55/58) WON 53.1% (34/64) 8 migration 28 occlusion 2 partially embedded stent 4 misdeployment WON 23 Song et al. [32 ], 2019, Korea PP 97.1% (33/34) PP 94.1% (32/34) 1 maldeployment 3 infection NA